Tutankhamun’s Antimalarial Drug for Covid-19
Open Access
- 30 October 2020
- journal article
- research article
- Published by Georg Thieme Verlag KG in Drug Research
- Vol. 71 (01) , 4-9
Abstract
Drug repositioning is a strategy that identifies new uses of approved drugs to treat conditions different from their original purpose. Current efforts to treat Covid-19 are based on this strategy. The first drugs used in patients infected with SARS-CoV-2 were antimalarial drugs. It is their mechanism of action, i. e., rise in endosomal pH, which recommends them against the new coronavirus. Disregarding their side effects, the study of their antiviral activity provides valuable hints for the choice and design of drugs against SARS-CoV-2. One prominent drug candidate is thymoquinone, an antimalarial substance contained in Nigella sativa – most likely one of the first antimalarial drugs in human history. Since the outbreak of the pandemic, the number of articles relating thymoquinone to Covid-19 continuously increases. Here, we use it as an exemplary model drug, compare its antiviral mechanism with that of conventional antimalarial drugs and establish an irreducible parametric scheme for the identification of drugs with a potential in Covid-19.Translation into the laboratory is simple. Starting with the discovery of Nigella sativa seeds in the tomb of Pharaoh Tutankhamun, we establish a physicochemical model for the interaction of thymoquinone with both coronavirus and cells. Exploiting the predictive capability of the model, we provide a generalizable scheme for the systematic choice and design of drugs for Covid-19. An unexpected offshoot of our research is that Tutankhamun could not have died of malaria, a finding contrary to the mainstream theory. Received: 01 September 2020 Accepted: 28 September 2020 Publication Date: 30 October 2020 (online) © 2020. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, GermanyKeywords
This publication has 29 references indexed in Scilit:
- Paleopathology of the juvenile Pharaoh Tutankhamun—90th anniversary of discoveryVirchows Archiv, 2013
- A review on therapeutic potential of Nigella sativa: A miracle herbAsian Pacific Journal of Tropical Biomedicine, 2013
- IN VITRO AND IN VIVO ANTI-PLASMODIAL ACTIVITY OF ESSENTIAL OILS, INCLUDING HINOKITIOL2012
- Shrinking the malaria map: progress and prospectsThe Lancet, 2010
- Malaria, mummies, mutations: Tutankhamun’s archaeological autopsyTropical Medicine & International Health, 2010
- Use of antimalarials in dermatologyJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2010
- Ancestry and Pathology in King Tutankhamun's FamilyJAMA, 2010
- Antiplasmodial Activity of Some Medicinal Plants Used in Sudanese Folk-medicineEnvironmental Health Insights, 2010
- In Vivo Anti-malarial Tests of Nigella sativa (Black Seed) Different ExtractsAmerican Journal of Pharmacology and Toxicology, 2007
- Effects of chloroquine on viral infections: an old drug against today's diseasesThe Lancet Infectious Diseases, 2003